Literature DB >> 12606521

The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma.

Christine Sempoux1, Yves Guiot, Karin Dahan, Pierre Moulin, Martine Stevens, Virginie Lambot, Pascale de Lonlay, Jean-Christophe Fournet, Claudine Junien, Francis Jaubert, Claire Nihoul-Fekete, Jean-Marie Saudubray, Jacques Rahier.   

Abstract

Paternal mutation of ATP-sensitive K(+) (K(ATP)) channel genes and loss of heterozygosity (LOH) of the 11p15 region including the maternal alleles of ABCC8, IGF2, and CDKN1C characterize the focal form of persistent hyperinsulinemic hypoglycemia of infancy (FoPHHI). We aimed to understand the actual nature of FoPHHI in comparison with insulinoma. In FoPHHI, the lesion consists in clusters of beta-cells surrounded by non-beta-cells. Compared with adjacent islets, proinsulin mRNA is similar and proinsulin production higher (P < or = 0.02), indicating regulation at a translational level, with slightly lower insulin stock and lower ABCC8 peptide labeling (P<0.05). Insulinomas, composed of beta-cell nests or cords, have similar proinsulin mRNA compared with adjacent islets, highly variable proinsulin production, lower insulin stock (P < or = 0.02), and higher ABCC8 peptide labeling (P<0.05). Proinsulin mRNA is lower than in FoPHHI (P<0.001). Islets adjacent to FoPHHI appear to be resting, in contrast to those adjacent to insulinomas, evidencing intrapancreatic regulation of islet beta-cell activity. IGF2 peptide is present inside and outside both lesions, but IGF2 mRNA is restricted to the lesions. The 11p15 LOH and absence of CDKN1C peptide staining are demonstrated in all FoPHHI but also in three of eight insulinomas. Despite some molecular similarities, FoPHHI is thus fundamentally different from insulinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606521     DOI: 10.2337/diabetes.52.3.784

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

1.  Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect.

Authors:  Tricia R Bhatti; Karthik Ganapathy; Alison R Huppmann; Laura Conlin; Kara E Boodhansingh; Courtney MacMullen; Susan Becker; Linda M Ernst; N Scott Adzick; Eduardo D Ruchelli; Arupa Ganguly; Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-01-12       Impact factor: 5.958

2.  In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.

Authors:  Jean-Claude Henquin; Myriam Nenquin; Christine Sempoux; Yves Guiot; Christine Bellanné-Chantelot; Timo Otonkoski; Pascale de Lonlay; Claire Nihoul-Fékété; Jacques Rahier
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

3.  Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications.

Authors:  Sanda Alexandrescu; Nina Tatevian; Oluyinka Olutoye; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-08-08

4.  Hyperinsulinemic hypoglycemia due to adult nesidioblastosis in insulin-dependent diabetes.

Authors:  A Raffel; M Anlauf; S-B Hosch; M Krausch; T Henopp; J Bauersfeld; R Klofat; D Bach; C-F Eisenberger; G Kloppel; W-T Knoefel
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

5.  Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.

Authors:  I A Leclercq; C Sempoux; P Stärkel; Y Horsmans
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

6.  Heterozygous inactivation of plasma membrane Ca(2+)-ATPase in mice increases glucose-induced insulin release and beta cell proliferation, mass and viability.

Authors:  Nathalie Pachera; Julien Papin; Francesco P Zummo; Jacques Rahier; Jan Mast; Kira Meyerovich; Alessandra K Cardozo; André Herchuelz
Journal:  Diabetologia       Date:  2015-09-11       Impact factor: 10.122

7.  The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.

Authors:  Maria-João Ribeiro; Nathalie Boddaert; Christine Bellanné-Chantelot; Sandrine Bourgeois; Vassili Valayannopoulos; Thierry Delzescaux; Francis Jaubert; Claire Nihoul-Fékété; Francis Brunelle; Pascale De Lonlay
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-28       Impact factor: 9.236

8.  Characterization of β-cell plasticity mechanisms induced in mice by a transient source of exogenous insulin.

Authors:  M-C Nollevaux; J Rahier; J Marchandise; P Thurion; S Godecharles; G Van den Steen; J Jamart; C Sempoux; P Jacquemin; Y Guiot
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

Review 9.  Advances in the diagnosis and management of hyperinsulinemic hypoglycemia.

Authors:  Ritika R Kapoor; Chela James; Khalid Hussain
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

10.  Persistent hyperinsulinemic hypoglycemia of infancy: a clinical and pathological study of 19 cases in a single institution.

Authors:  Jiwei Li; Yangyang Ma; Mengxing Lv; Jun Zhou; Baihui Liu; Kuiran Dong; Xianmin Xiao; Lian Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.